Cat Cancer Pain Management: Evidence and Welfare Best Practice

Pain management in feline oncology remains one of the most significant welfare gaps in companion animal medicine, with cats frequently undertreated due to diagnostic difficulty and owner compliance barriers.

Key Facts

Cats mask pain behaviour effectively due to evolutionary predator-avoidance instincts, making pain assessment challenging
Validated feline pain assessment tools include the Glasgow Composite Measure Pain Scale (short form) and UNESP-Botucatu scales
NSAIDs are the most effective oral analgesics for cancer pain in cats but require monitoring for renal and hepatic effects
Buprenorphine administered transmucosally is well-tolerated by cats and provides effective moderate pain control
Gabapentin addresses neuropathic cancer pain and has excellent safety and tolerability in cats

Welfare Considerations

Feline cancer pain welfare requires veterinary teams and owners to overcome the masking behaviour that makes cats appear comfortable when they are suffering. Using validated pain scales at every oncology appointment and treating proactively — before pain scores become high — rather than reactively delivers substantially better welfare outcomes. Owner education about subtle feline pain signals (reduced grooming, reduced interaction, changed posture, altered gait) is essential for at-home welfare monitoring. Multimodal analgesia combining NSAID, opioid, and gabapentinoid components provides the best coverage.

What You Can Do

Ask your vet to use a validated feline pain scale at every cancer follow-up appointment
Learn to recognise subtle feline pain signals — reduced grooming, hunched posture, reduced interaction, and gait changes
Discuss multimodal pain management with your veterinarian rather than relying on a single analgesic